Selma M. van Dam

Aprepitant inhibits cyclophosphamide bioactivation and thiotepa metabolism

Milly E. de Jonge, Alwin D. R. Huitema, M. Holtkamp et al. · Cancer Chemotherapy and Pharmacology · 2005 · 64 citations

Medicine, Pharmacology, Pharmacotherapy +7

Simultaneous quantification of cyclophosphamide, 4‐hydroxycyclophosphamide, <i>N</i>,<i>N</i>^′,<i>N</i>^″‐triethylenethiophosphoramide (thiotepa) and <i>N</i>,<i>N</i>^′,<i>N</i>^″‐triethylenephosphoramide (tepa) in human plasma by high‐performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry

Milly E. de Jonge, Selma M. van Dam, M. J. X. Hillebrand et al. · Journal of Mass Spectrometry · 2004 · 61 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Significant induction of cyclophosphamide and thiotepa metabolism by phenytoin

Milly E. de Jonge, Alwin D. R. Huitema, Selma M. van Dam et al. · Cancer Chemotherapy and Pharmacology · 2005 · 42 citations

Medicine, Pharmacokinetics, Pharmacology +8

Population Pharmacokinetics of Cyclophosphamide and Its Metabolites 4-Hydroxycyclophosphamide, 2-Dechloroethylcyclophosphamide, and Phosphoramide Mustard in a High-Dose Combination With Thiotepa and Carboplatin

Milly E. de Jonge, Alwin D. R. Huitema, Selma M. van Dam et al. · Therapeutic Drug Monitoring · 2005 · 29 citations

Pharmacy, Pharmacokinetics, Pharmacology +10

Accuracy, Feasibility, and Clinical Impact of Prospective Bayesian Pharmacokinetically Guided Dosing of Cyclophosphamide, Thiotepa, and Carboplatin in High-Dose Chemotherapy

Milly E. de Jonge, Alwin D. R. Huitema, Annemarie C. Tukker et al. · Clinical Cancer Research · 2005 · 18 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17